Merge eFilm Expands VAR Partnership Strategy in Europe; Partners bring Merge eFilm's integrated, scalable and affordable FUSION solution to local markets.
Milwaukee, WI, October 22, 2002

Milwaukee, WI, October 22, 2002 - Merge eFilm (Nasdaq: MRGE), a medical image and information management solutions provider, today announced new and expanded partnership agreements with four European medical suppliers to become authorized providers of Merge eFilm solutions.

The four VAR partners in the program are TPS Medical, a UK medical imaging company based in Scotland, with extensive experience in Merge eFilm solutions; Xograph Imaging Systems Ltd, a medical imaging company in the UK, based in Gloucestershire, specializing in digital imaging and PACS solutions; WESTMEDIA, a Germany-based company offering components from Merge eFilm's solutions bundled with its RIS-PACS PowerPack; and Aycan Digitalsysteme GmbH, headquartered in Wuerzburg Germany, specializing in marketing products and software for medical imaging and PACS.

"We are pleased that our partners understand the Merge eFilm value proposition, appreciate the unique approach of our FUSION image and information solution suite, and embrace our approach to consultative solution design and customer service," said Rich Linden, President and CEO of Merge eFilm.

"The recognition of the value of a filmless environment by the European community is clear, and the marketplace timing for having an affordable, scalable solution that improves productivity and enhances patient care is right. We have already seen the value of these VAR partnerships with the successful sale and deployment of our FUSION image and information solution suite at several European healthcare customer sites. We look forward to the continued growth of these partnerships and our presence in the European market."

Press Contact
Attn: Beth Frost-Johnson Merge Healthcare 6737 West Washington St. Suite 2250 Milwaukee, WI 53214		Phone: 1-(414) 977-4254
Email Address: marketing@merge.com
Except for the historical information herein, the matters discussed in this news release include forward-looking statements that may involve a number of risks and uncertainties. When used in this press release, the words “will,” “believes,” “intends,” “anticipates,” “expects” and similar expressions are intended to identify forward-looking statements. Actual results could differ materially from those expressed in, or implied by, the forward-looking statements based on a number of factors, including, but not limited to, the uncertainty created by, the adverse impact on relationships with customers, potential customers, suppliers and investors potentially resulting from, and other risks associated with, the changes in the Company’s senior management; costs, risks and effects of the investigation by the Audit Committee of the Board of Directors; the impact of the restatement of financial statements of the Company and other actions that may be taken or required as a result of such restatement; the Company's inability to timely file reports with the Securities and Exchange Commission; risks associated with the Company's inability to meet the requirements of The NASDAQ Stock Market for continued listing, including possible delisting; costs, risks and effects of legal proceedings and investigations, including the informal, non-public inquiry being conducted by the Securities and Exchange Commission and class action, derivative, and other lawsuits; risks in product and technology development, market acceptance of new products and continuing product demand, the impact of competitive products and pricing, ability to integrate acquisitions, changing economic conditions, credit and payment risks associated with end-user sales, dependence on major customers, dependence on key personnel, and other risk factors detailed in the Company’s filings with the Securities and Exchange Commission. Except as expressly required by the federal securities laws, the Company undertakes no obligation to update such factors or to publicly announce the results of any of the forward-looking statements contained herein to reflect future events, developments, or changed circumstances, or for any other reason.